Greenbrook TMS NeuroHealth Centers
As the CEO of Greybrook Securities Inc., Sasha, is responsible for co-managing the firm's operation and investment strategy. Together with his partners, Sasha has played a significant role in growing Greybrook’s real estate investment portfolio to include over 80 multi-family and residential development projects throughout North America, representing over $17 billion worth of estimated completion value. Under Sasha’s leadership, the firm currently manages over $1.2 billion of equity on behalf of more than 6,800 high net worth individual and institutional clients located in over 30 countries. Sasha also serves as the Co-chair of Greybrook’s Investment and Project Advisory Committees where he is part of the team responsible for approving new acquisitions and overseeing existing limited partnerships.
This person is not in the org chart
This person is not in any offices
Greenbrook TMS NeuroHealth Centers
Greenbrook TMS NeuroHealth is the nation’s leading provider of Transcranial Magnetic Stimulation (TMS) therapy, an FDA-cleared, non-invasive therapy for the treatment of Major Depressive Disorder and Obsessive-Compulsive Disorder. Since 2011, they've provided more than 320,000 life-changing TMS treatments to over 9,000 patients.